These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 39211552)
1. Primary intestinal diffuse large B-cell lymphoma: novel insights and clinical perception. Chen X; Wang J; Liu Y; Lin S; Shen J; Yin Y; Wang Y Front Oncol; 2024; 14():1404298. PubMed ID: 39211552 [TBL] [Abstract][Full Text] [Related]
2. [Clinical Features and Prognosis of Secondary Intestinal Diffuse Large B-Cell Lymphoma]. Chen XJ; Lin SX; Gan DH; Shen JZ; Fu YM; Yin Y; Zeng MJ; Liu YQ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Aug; 32(4):1097-1105. PubMed ID: 39192404 [TBL] [Abstract][Full Text] [Related]
3. [Evaluation of different staging systems and prognostic analysis of 110 primary gastrointestinal diffuse large B cell lymphoma]. Mao L; Wang X; Wang CY; Xia B; Ning QY; Yang HL; Yu Y; Zhang YZ Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(24):1853-1858. PubMed ID: 31269579 [No Abstract] [Full Text] [Related]
4. [Comparison the efficacy and prognosis of different first-line treatment for elderly diffuse large B-cell lymphoma]. Liu P; Jiang SY; He XH; Qin Y; Gui L; Zhou SY; Yang JL; Yang S; Wen TY; Shi YK Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):234-241. PubMed ID: 32252203 [No Abstract] [Full Text] [Related]
5. Clinical characteristics and outcomes of patients with diffuse large B cell lymphoma treated with R-CHOP-like or CHOP-like regimens: an 8-year experience from a single center. Huang H; Fan L; Fu D; Lin Q; Shen J Ann Palliat Med; 2020 Jul; 9(4):1442-1452. PubMed ID: 32648457 [TBL] [Abstract][Full Text] [Related]
6. Clinical prognostic factors of diffuse large B cell non-Hodgkin lymphoma: a retrospective study. Abdelhamid T; Samra M; Ramadan H; Mehessin M; Mokhtar N J Egypt Natl Canc Inst; 2011 Mar; 23(1):17-24. PubMed ID: 22099932 [TBL] [Abstract][Full Text] [Related]
7. [Comparison of the Prognostic Value of C-Reactive Protein to Albumin Ratio and Glasgow Prognostic Score in Patients with Diffuse Large B-Cell Lymphoma]. Wang HY; Deng H; Huang MJ; Zhang L; Chen TR; Liu Y; Zou XL Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Jun; 32(3):742-749. PubMed ID: 38926961 [TBL] [Abstract][Full Text] [Related]
8. R-CHOP immunochemotherapy plus surgery is associated with a superior prognosis in Chinese primary intestinal diffuse large B-cell lymphoma. Zhao F; Qin Y; Yang J; Liu P; He X; Zhou L; Zhou S; Gui L; Zhang H; Wang X; Jiang S; Zhong Q; Zhou Y; Shi Y Asia Pac J Clin Oncol; 2020 Dec; 16(6):385-391. PubMed ID: 32779387 [TBL] [Abstract][Full Text] [Related]
9. [Comparison of Different Staging Systems and Prognostic Analysis in 68 Cases of Primary Intestinal Diffuse Large B Cell Lymphoma]. Wang X; Wang CY; Xu W; Yang HL; Zhao HF; Wang XF; Wang YF; Yu Y; Zhang YZ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):52-60. PubMed ID: 30738447 [TBL] [Abstract][Full Text] [Related]
10. [Primary Extranodal Diffuse Large B-Cell Lymphoma in the Rituximab Era: a Single-Center Retrospective Analysis]. Yang L; Cao LX; Ren HJ; Han YQ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Aug; 32(4):1121-1128. PubMed ID: 39192408 [TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and treatment outcomes of Chinese diffuse large B-cell lymphoma patients in the era of rituximab (2005-2018). Shi Y; Chen H; Qin Y; Yang J; Liu P; He X; Zhou S; Zhou L; Zhang C; Song Y; Liu Y; Gui L; Wang S; Jin J; Fang H; Qi S; Li N; Tang Y; Wang X; Yang S Cancer Pathog Ther; 2023 Jan; 1(1):3-11. PubMed ID: 38328609 [TBL] [Abstract][Full Text] [Related]
12. [Prognosis analysis of primary breast diffuse large B cell lymphoma]. Zhu YH; Meng WJ; He LH; Jia YS; Tong ZS Zhonghua Zhong Liu Za Zhi; 2019 Mar; 41(3):235-240. PubMed ID: 30917462 [No Abstract] [Full Text] [Related]
13. [Retrospective analysis of the clinical features and prognostic factors of 370 patients with advanced-stage diffuse large B-cell lymphoma]. Han Y; Qin Y; He XH; Yang JL; Liu P; Zhang CG; Zhou LQ; Zhou SY; Gui L; Song YW; Sun Y; Shi YK Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):456-461. PubMed ID: 29936773 [No Abstract] [Full Text] [Related]
14. [Efficacy of surgery and rituximab in primary gastric diffuse large B-cell lymphoma]. Huang HW; Jiang YB; Fu TW; Xu T; Chen XC; Jin ZM; Wu DP Zhonghua Xue Ye Xue Za Zhi; 2016 Jul; 37(7):602-6. PubMed ID: 27535862 [TBL] [Abstract][Full Text] [Related]
15. [Clinicopathological characteristics and prognostic analysis of primary intestinal diffuse large B-cell lymphoma]. Huang Y; Zhou S; He X; Gui L; Yang J; Liu P; Qin Y; Zhang C; Xing P; Yang S; Wang L; Zhou L; Dong M; Sun Y; Shi Y Zhonghua Yi Xue Za Zhi; 2015 Dec; 95(48):3895-8. PubMed ID: 27122208 [TBL] [Abstract][Full Text] [Related]
16. [Clinical characteristics and prognostic features of 63 HIV-associated diffuse large B-cell lymphoma: a single-center real-world study in China]. Wang CY; Liu J; Liang XP; Guo BL; Hu RZ; Liu Y Zhonghua Xue Ye Xue Za Zhi; 2022 Mar; 43(3):203-208. PubMed ID: 35405777 [No Abstract] [Full Text] [Related]
17. [Clinical characteristics, cell origin and prognosis of primary gastrointestinal diffuse large B-cell lymphoma: a report of 40 cases]. Yang YL; Wang J; Zhao LZ; Gao ZF; Jing HM; Ke XY Ai Zheng; 2008 Jun; 27(6):636-41. PubMed ID: 18570740 [TBL] [Abstract][Full Text] [Related]
18. [Expression of CD30 in Patients with Diffuse Large B-Cell Lymphoma and Clinical Significance]. Qu Y; Lu XZ; Wang RX; Hei XF; Li J; Xiao BT; Jia ZX Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):450-457. PubMed ID: 38660851 [TBL] [Abstract][Full Text] [Related]
19. [Expression of dendritic cell marker CD21 is a positive prognostic factor in diffuse large B-cell lymphoma]. Yao WK; Wang YP; Peng F; Zheng Y; Zou YB; Gao JN; Liu XL Zhonghua Bing Li Xue Za Zhi; 2012 Dec; 41(12):818-22. PubMed ID: 23324230 [TBL] [Abstract][Full Text] [Related]
20. [A retrospective analysis of clinical characteristics and prognostic factors for 124 cases of primary gastric lymphomas]. He Y; Wang L; Zhu HY; Liang JH; Wu W; Wu JZ; Xia Y; Cao L; Fan L; Li JY; Xu W Zhonghua Xue Ye Xue Za Zhi; 2017 Jun; 38(6):505-510. PubMed ID: 28655094 [No Abstract] [Full Text] [Related] [Next] [New Search]